The influence of antigen organization on B cell responsiveness.
暂无分享,去创建一个
R. Zinkernagel | T. Kündig | M. Bachmann | H. Hengartner | K. Bürki | U. Rohrer | Hans Hengartner | H. Hengartner
[1] R. Zinkernagel,et al. Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses , 1993, Journal of virology.
[2] R. Zinkernagel,et al. Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus , 1993, Journal of virology.
[3] H. Eibel,et al. B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain , 1991, The Journal of experimental medicine.
[4] C. Goodnow,et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens , 1991, Nature.
[5] R. Zinkernagel,et al. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Pircher,et al. T and B cell Tolerance and Responses to Viral Antigens in Transgenic Mice: Implications for the Pathogenesis of Autoimmune versus Immunopathological Disease , 1991, Immunological reviews.
[7] G. Morahan,et al. Clonal Deletion of Autospecific B Lymphocytes , 1991, Immunological reviews.
[8] C. Goodnow,et al. Self Tolerance in the B‐Cell Repertoire , 1991, Immunological reviews.
[9] C. Goodnow,et al. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. , 1991, Science.
[10] R. Hardy,et al. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice , 1991, Nature.
[11] R. Zinkernagel,et al. Analysis of the kinetics of antiviral memory T help in vivo: characterization of short‐lived cross‐reactive T help , 1990, European journal of immunology.
[12] C. Goodnow,et al. Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Zinkernagel,et al. Virus-induced autoantibody response to a transgenic viral antigen , 1990, Nature.
[14] H. Dintzis,et al. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. , 1989, Journal of immunology.
[15] D. Nemazee,et al. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes , 1989, Nature.
[16] S. Smith‐Gill,et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.
[17] M. Simon,et al. Alloreactive immune responses of transgenic mice expressing a foreign transplantation antigen in a soluble form. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Steward,et al. An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. , 1988, Journal of immunological methods.
[19] R. Zinkernagel,et al. Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies , 1987, Journal of virology.
[20] R. Zinkernagel,et al. Functional analysis of T lymphocyte subsets in antiviral host defense. , 1987, Journal of immunology.
[21] B. Moss,et al. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes , 1986, The Journal of experimental medicine.
[22] R. Zinkernagel,et al. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. , 1986, Journal of immunology.
[23] D. Moskophidis,et al. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection. , 1984, Journal of immunology.
[24] L. Lefrançois,et al. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes. , 1982, Virology.
[25] L. Lefrançois,et al. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. , 1982, Virology.
[26] B. Vogelstein,et al. Molecular determinants of immunogenicity: the immunon model of immune response. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Notkins,et al. Thymus dependence of viral antigens , 1975, Nature.
[28] D. Drachman,et al. Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors , 1973, Science.
[29] S. Emerson,et al. The Glycoprotein of Vesicular Stomatitis Virus Is the Antigen That Gives Rise to and Reacts with Neutralizing Antibody , 1972, Journal of virology.
[30] C. Goodnow. Transgenic mice and analysis of B-cell tolerance. , 1992, Annual review of immunology.
[31] J. Lindstrom. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome. , 1985, Annual review of immunology.